Novel Factor Xa Inhibitor for the Treatment of Cerebral Venous and Sinus Thrombosis | Zendy

C. Geisbüsch | Zendy; Daniel Richter | Zendy; Christian Herweh | Zendy; Peter A. Ringleb | Zendy; Simon Nagel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Novel Factor Xa Inhibitor for the Treatment of Cerebral Venous and Sinus Thrombosis

Author(s) -

C. Geisbüsch,

Daniel Richter,

Christian Herweh,

Peter A. Ringleb,

Simon Nagel

Publication year - 2014

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.114.006167

Subject(s) - medicine , modified rankin scale , rivaroxaban , venous thrombosis , phenprocoumon , cerebral venous sinus thrombosis , thrombosis , intracranial thrombosis , stroke (engine) , surgery , gastroenterology , warfarin , atrial fibrillation , ischemic stroke , ischemia , mechanical engineering , engineering

Thrombosis of cerebral veins and sinus (cerebral venous thrombosis) is a rare stroke pathogenesis. Pharmaceutical treatment is restricted to heparin and oral anticoagulation with vitamin K antagonists (VKAs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research